Literature DB >> 29425276

Giant Cell Tumor of Bone in Patients 55 Years and Older: A Study of 34 Patients.

Cory J Broehm1, Carrie Y Inwards1, Alyaa Al-Ibraheemi1, Doris E Wenger2, Sarah M Jenkins3, Long Jin1, Andre M Oliveira1, Riyam T Zreik4, Jodi M Carter1, Jennifer M Boland1, Karen J Fritchie1.   

Abstract

OBJECTIVES: Most giant cell tumors of bone (GCTs) occur in patients aged 20 to 40 years. We analyzed features of GCT in patients 55 years or older.
METHODS: GCTs were examined for fibrosis, matrix, cystic change, histiocytes, mitoses, and necrosis. Clinical/radiologic data were collected.
RESULTS: Thirty-four (5%) of 710 GCTs occurred in patients older than 55 years (14/20 male/female; 56-83 years) in long bones (n = 24), vertebrae (n = 6), pelvis (n = 3), and metacarpal (n = 1). Imaging was classic in 26 of 27 cases; one case appeared malignant. Morphologic patterns included fibrosis (n = 29), bone formation (n = 19), cystic change (n = 8), necrosis (n = 8), foamy histiocytes (n = 7), and secondary aneurysmal bone cyst formation (n = 1). Mitoses ranged from 0 to 18 per 10 high-power fields. Six recurred; one patient developed metastasis. Four of five cases harbored H3F3A mutations.
CONCLUSIONS: GCTs in patients 55 years or older share pathologic characteristics with those arising in younger adults. Fibrosis and reactive bone are common, potentially leading to diagnostic confusion in this population. No histologic features correlate with adverse outcome. © American Society for Clinical Pathology, 2018. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com

Entities:  

Mesh:

Year:  2018        PMID: 29425276     DOI: 10.1093/ajcp/aqx155

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  6 in total

Review 1.  Management of giant cell tumors of the distal radius: a systematic review and meta-analysis.

Authors:  Robert Koucheki; Aaron Gazendam; Jonathan Perera; Anthony Griffin; Peter Ferguson; Jay Wunder; Kim Tsoi
Journal:  Eur J Orthop Surg Traumatol       Date:  2022-03-30

2.  Giant cell tumor of bone: a report of two cases with metaphyseal lesions and their progression to the articular surface.

Authors:  Stephen Wahl; Gregory Domson; Anna Greenwood; Anthony Skaff
Journal:  Int Cancer Conf J       Date:  2021-09-21

3.  H3F3A G34 mutation DNA sequencing and G34W immunohistochemistry analysis in 366 cases of giant cell tumors of bone and other bone tumors.

Authors:  Lihua Gong; Marilyn M Bui; Wen Zhang; Xiaoqi Sun; Ming Zhang; Ding Yi
Journal:  Histol Histopathol       Date:  2020-09-04       Impact factor: 2.303

4.  Giant Cell Tumors of Bone in Patients Aged 18 Years Old or Younger: Imaging Features and Tumor Characteristics.

Authors:  Xue-Ping Zhang; Xin-Chang Lu; Lin-Lin Wang; Jie-Qin Wei; Jing Yan; Xiao-Ning Shao; Ying-Yu Che; Jing-Liang Cheng
Journal:  Int J Gen Med       Date:  2021-11-18

5.  Diagnosis of bone giant cell tumor in elderly patient: A case report of an unusual case.

Authors:  Paulus Raharjo; Rosy Setiawati
Journal:  Ann Med Surg (Lond)       Date:  2022-06-29

6.  Denosumab for Effective Tumor Size Reduction in Patients With Giant Cell Tumors of the Bone: A Systematic Review and Meta-Analysis.

Authors:  Josef Yayan
Journal:  Cancer Control       Date:  2020 Jul-Aug       Impact factor: 3.302

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.